Project Details
| Acronym | M14-234 |
|---|---|
| Status | Active |
| Effective start/end date | 17/12/19 → 24/09/24 |
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Upadacitinib (ABT-494) for Induction and Maintenance Therapy in Subjects with Moderately to Severely Active Ulcerative Colitis
- Leong, Rupert (Primary Chief Investigator)
- Chapman, Nicola (Clinical Trial Unit Staff)
- Parshionikar, Abhijit (Clinical Trial Unit Staff)
Project: Research